Basic Information
RNALocate ID: | RLID:02000604 |
RNA Symbol: | MEG3 |
Localization: | Nucleus |
RNA Information
RNA Name: | MEG3 |
RNA ID: | NCBI:55384|Ensembl:ENSG00000214548 |
RNA Category: | lncRNA |
Species: | Homo sapiens |
Alias: | FP504|GTL2|LINC00023|NCRNA00023|PRO0518|PRO2160|onco-lncRNA-83|prebp1 |
Localization Information
PubMed ID: | 25630241 |
Tissue/Cell Line: | Lung fibroblasts |
Method: | FISH|qRT-PCR|smFISH |
White points represent transcript spots, and blue region is the nuclear region. Originally published in Genome Biol. Cabili MN, et al, 2015. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | LncRNAs exhibit a variety of cellular localization patterns. Florescence micrographs of representative expressing cells for each of 34 lncRNAs with a validated probe set. LncRNA-cell pairs are classified to cellular localization types I to V as described in the Methods (marked by their border color). Magenta stars mark five lncRNAs that are presented in two different cell types and two different classes (see same row for comparison).Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:02000599 | Cytoplasm | Hepatoma cells | 21625215 |
RLID:02000600 | Endoplasmic reticulum | Human myelogenous leukemia cell line (K-562) | 21613539 |
RLID:02000601 | Nucleus | Cell line (BT-549) | 26205790 |
RLID:02000602 | Nucleus | HeLa cells | 31107149 |
RLID:02000603 | Nucleus | Cell lines (GM12878|HeLaS3|HepG2)|Human umbilical vein endothelial cells | 22955988 |
RLID:02001151 | Cytoplasm | Human lens epithelial cells (SRA01/04) | 32841649 |
RLID:02001152 | Nucleus | Human lens epithelial cells (SRA01/04) | 32841649 |
RLID-D:12005230 | Exosome | Serum |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | MEG3 | Phaeochromocytoma | MNDR-E-LNC-17886 |
MNDR | MEG3 | Renal fibrosis | MNDR-E-LNC-17887 |
MNDR | MEG3 | Tongue squamous cell carcinoma | MNDR-E-LNC-17888 |
MNDR | MEG3 | Oral squamous cell carcinoma | MNDR-E-LNC-17889 |
MNDR | MEG3 | Myelodysplastic syndrome | MNDR-E-LNC-17890 |
MNDR | MEG3 | Prostate cancer | MNDR-E-LNC-17891 |
MNDR | MEG3 | Hirschsprung disease | MNDR-E-LNC-17892 |
MNDR | MEG3 | Gastric cancer | MNDR-E-LNC-17893 |
MNDR | MEG3 | Pre-eclampsia | MNDR-E-LNC-17894 |
MNDR | MEG3 | Bladder cancer | MNDR-E-LNC-17895 |
MNDR | MEG3 | Huntington disease | MNDR-E-LNC-17896 |
MNDR | MEG3 | Cardiovascular disease | MNDR-E-LNC-17897 |
MNDR | MEG3 | Lung cancer | MNDR-E-LNC-17898 |
MNDR | MEG3 | Endometrial cancer | MNDR-E-LNC-17899 |
MNDR | MEG3 | Metabolic syndrome | MNDR-E-LNC-17900 |
MNDR | MEG3 | Breast cancer | MNDR-E-LNC-17901 |
MNDR | MEG3 | Cancer | MNDR-E-LNC-17902 |
MNDR | MEG3 | Ventricular septal defect | MNDR-E-LNC-17903 |
MNDR | MEG3 | Thyroid cancer | MNDR-E-LNC-17904 |
MNDR | MEG3 | Clinical nonfunctioning pituitary adenoma | MNDR-E-LNC-17905 |
MNDR | MEG3 | Pancreatic cancer | MNDR-E-LNC-17906 |
MNDR | MEG3 | Pancreatic endocrine carcinoma | MNDR-E-LNC-17907 |
MNDR | MEG3 | Pancreatic neuroendocrine tumor | MNDR-E-LNC-17908 |
MNDR | MEG3 | Melanoma | MNDR-E-LNC-17909 |
MNDR | MEG3 | Atherosclerosis | MNDR-E-LNC-17910 |
MNDR | MEG3 | Vulva squamous cell carcinoma | MNDR-E-LNC-17911 |
MNDR | MEG3 | Epithelial ovarian cancer | MNDR-E-LNC-17912 |
MNDR | MEG3 | Nephroblastoma | MNDR-E-LNC-17913 |
MNDR | MEG3 | Colon cancer | MNDR-E-LNC-17914 |
MNDR | MEG3 | Ovarian cancer | MNDR-E-LNC-17915 |
MNDR | MEG3 | Hemangioma | MNDR-E-LNC-17916 |
MNDR | MEG3 | Kidney cancer | MNDR-E-LNC-17917 |
MNDR | MEG3 | Carcinoma endometrial | MNDR-E-LNC-17918 |
MNDR | MEG3 | Laryngeal squamous cell cancer | MNDR-E-LNC-17919 |
MNDR | MEG3 | Glioblastoma | MNDR-E-LNC-17920 |
MNDR | MEG3 | Glioma | MNDR-E-LNC-17921 |
MNDR | MEG3 | Chronic obstructive pulmonary disease | MNDR-E-LNC-17922 |
MNDR | MEG3 | Gallbladder cancer | MNDR-E-LNC-17923 |
MNDR | MEG3 | Embryonal rhabdomyosarcoma | MNDR-E-LNC-17924 |
MNDR | MEG3 | Osteosarcoma | MNDR-E-LNC-17925 |
MNDR | MEG3 | Pancreatic ductal adenocarcinoma | MNDR-E-LNC-17926 |
MNDR | MEG3 | Meningioma | MNDR-E-LNC-17927 |
MNDR | MEG3 | Liver cancer | MNDR-E-LNC-17928 |
MNDR | MEG3 | Choriocarcinoma | MNDR-E-LNC-17929 |
MNDR | MEG3 | Gastric adenocarcinoma | MNDR-E-LNC-17930 |
MNDR | MEG3 | Esophagus squamous cell carcinoma | MNDR-E-LNC-17931 |
MNDR | MEG3 | Non-functioning pituitary adenoma | MNDR-E-LNC-17932 |
MNDR | MEG3 | Lung squamous cell carcinoma | MNDR-E-LNC-17933 |
MNDR | MEG3 | Carcinoma lung non-small-cell | MNDR-E-LNC-17934 |
MNDR | MEG3 | Lung adenocarcinoma | MNDR-E-LNC-17935 |
MNDR | MEG3 | Thyroid carcinoma | MNDR-E-LNC-17936 |
MNDR | MEG3 | Papillary thyroid cancer | MNDR-E-LNC-17937 |
MNDR | MEG3 | Bladder urothelial carcinoma | MNDR-E-LNC-17938 |
MNDR | MEG3 | Valvulopathy | MNDR-E-LNC-17939 |
MNDR | MEG3 | Liver disease | MNDR-E-LNC-17940 |
MNDR | MEG3 | Cervical cancer | MNDR-E-LNC-17941 |
MNDR | MEG3 | Renal cell carcinoma | MNDR-E-LNC-17942 |
MNDR | MEG3 | Clear cell renal cell carcinoma | MNDR-E-LNC-17943 |
MNDR | MEG3 | Cholangiocarcinoma | MNDR-E-LNC-17944 |
MNDR | MEG3 | Myelofibrosis | MNDR-E-LNC-17945 |
MNDR | MEG3 | Esophageal cancer | MNDR-E-LNC-17946 |
MNDR | MEG3 | Liver cirrhosis | MNDR-E-LNC-17947 |
MNDR | MEG3 | Head and neck squamous cell carcinoma | MNDR-E-LNC-17948 |
MNDR | MEG3 | Testicular germ cell cancer | MNDR-E-LNC-17949 |
MNDR | MEG3 | Functionless pituitary adenoma | MNDR-E-LNC-17950 |
MNDR | MEG3 | Gastric cardia adenocarcinoma | MNDR-E-LNC-17951 |
MNDR | MEG3 | Hypoxia-induced pulmonary hypertension | MNDR-E-LNC-17952 |
MNDR | MEG3 | Pulmonary hypertension | MNDR-E-LNC-17953 |
MNDR | MEG3 | Cerebrovascular disease | MNDR-E-LNC-17954 |
MNDR | MEG3 | Hepatocellular carcinoma | MNDR-E-LNC-17955 |
MNDR | MEG3 | Cervical carcinoma | MNDR-E-LNC-17956 |
MNDR | MEG3 | Intraductal papillary mucinous neoplasms of the pancreas | MNDR-E-LNC-17957 |
MNDR | MEG3 | Retinoblastoma | MNDR-E-LNC-17958 |
MNDR | MEG3 | Neuroblastoma | MNDR-E-LNC-17959 |
MNDR | MEG3 | Osteoarthritis | MNDR-E-LNC-17960 |
MNDR | MEG3 | Chronic myeloid leukemia | MNDR-E-LNC-17961 |
MNDR | MEG3 | Immune thrombocytopenia | MNDR-E-LNC-17962 |
MNDR | MEG3 | Acute myeloid leukemia | MNDR-E-LNC-17963 |
MNDR | MEG3 | Colorectal cancer | MNDR-E-LNC-17964 |
MNDR | MEG3 | Nasopharyngeal carcinoma | MNDR-E-LNC-17965 |
MNDR | MEG3 | Nasopharynx carcinoma | MNDR-E-LNC-17966 |
MNDR | MEG3 | Diabetes mellitus | MNDR-E-LNC-17967 |
MNDR | MEG3 | Multiple myeloma | MNDR-E-LNC-17968 |
MNDR | MEG3 | Type 1 diabetes mellitus | MNDR-E-LNC-17969 |
MNDR | MEG3 | Heroin dependence | MNDR-E-LNC-17970 |
MNDR | MEG3 | Ovarian epithelial cancer | MNDR-E-LNC-17971 |
MNDR | MEG3 | Esophageal squamous cell cancer | MNDR-E-LNC-17972 |
MNDR | MEG3 | Uterine cervical neoplasms | MNDR-E-LNC-17973 |
MNDR | MEG3 | Liver fibrosis | MNDR-E-LNC-17974 |
MNDR | MEG3 | Nasopharyngeal cancer | MNDR-E-LNC-17975 |
MNDR | MEG3 | Prostate | MNDR-E-LNC-17976 |
MNDR | MEG3 | Purpura thrombocytopenic | MNDR-E-LNC-17977 |
MNDR | MEG3 | Stroke | MNDR-E-LNC-17978 |
MNDR | MEG3 | T-cell lymphoblastic lymphoma | MNDR-E-LNC-17979 |
MNDR | MEG3 | Liver ischemia/reperfusion(i/r)injury | MNDR-E-LNC-17980 |
MNDR | MEG3 | Spiral artery remodeling | MNDR-E-LNC-17981 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022756 |
TOP